Secondary prevention of hepatitis C virus-related hepatocellular carcinoma.
Lin
Shi-Ming
SM
Chu
Chia-Ming
CM
D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control* / Q000821:virology*; D004359:Drug Therapy, Combination; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons